127 related articles for article (PubMed ID: 10182972)
1. Breast Cancer Prevention Trial is a raging success.
Med Manag Netw; 1998 May; 6(5):5-7. PubMed ID: 10182972
[No Abstract] [Full Text] [Related]
2. Breast Cancer Prevention Trial shows major benefit, some risk.
Jpn J Clin Oncol; 1998 Jun; 28(6):417-8. PubMed ID: 9730162
[No Abstract] [Full Text] [Related]
3. Chemoprevention of breast cancer.
Dalton RR; Kallab AM
South Med J; 2001 Jan; 94(1):7-15. PubMed ID: 11213947
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer risks and prevention: implications of the Breast Cancer Prevention Trial results.
Crowell EB; Jubelirer SJ
W V Med J; 2000; 96(6):598-601. PubMed ID: 11194088
[TBL] [Abstract][Full Text] [Related]
5. Cancer institute to tighten control of trials.
Gavaghan H
Nature; 1994 Apr; 368(6473):679. PubMed ID: 8152474
[No Abstract] [Full Text] [Related]
6. Re: Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
Cuzick J; Forbes JF; Howell A
J Natl Cancer Inst; 2006 May; 98(9):643; author reply 643-4. PubMed ID: 16670391
[No Abstract] [Full Text] [Related]
7. Prevention of breast cancer in high-risk women.
Kardinal CG; Veith R
J La State Med Soc; 1999 Apr; 151(4):198-201. PubMed ID: 10234895
[TBL] [Abstract][Full Text] [Related]
8. Follow-up of the breast cancer prevention trial and the future of breast cancer prevention efforts.
Vogel VG
Clin Cancer Res; 2001 Dec; 7(12 Suppl):4413s-4418s; discussion 4411s-4412s. PubMed ID: 11916233
[TBL] [Abstract][Full Text] [Related]
9. Independent assessment supports a role for tamoxifen in breast cancer risk reduction.
Oncology (Williston Park); 1999 Sep; 13(9):1211. PubMed ID: 10509317
[No Abstract] [Full Text] [Related]
10. The cost effectiveness of tamoxifen in the prevention of breast cancer.
Noe LL; Becker RV; Gradishar WJ; Gore M; Trotter JP
Am J Manag Care; 1999 Jun; 5(6 Suppl):S389-406. PubMed ID: 10538851
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer risk reduction: what do we know and where should we go?
Prout MN
Medscape Womens Health; 2000; 5(5):E4. PubMed ID: 11113777
[TBL] [Abstract][Full Text] [Related]
12. NCI director opts against breast cancer prevention trial in favor of biomarkers.
Savage L
J Natl Cancer Inst; 2007 Sep; 99(17):1282-3, 1289. PubMed ID: 17728206
[No Abstract] [Full Text] [Related]
13. [A United States National Institutes of Health investigation suspended due to risk of breast cancer with use of hormone replacement in menopause].
Zárate-Treviño A
Gac Med Mex; 2002; 138(6):595-6. PubMed ID: 12532629
[No Abstract] [Full Text] [Related]
14. Hope for axed cancer-prevention trial.
Wadman M
Nature; 2007 Aug; 448(7156):850. PubMed ID: 17713497
[No Abstract] [Full Text] [Related]
15. Clinical research. No lifeline for proposed breast cancer prevention trial.
Kaiser J
Science; 2007 Jun; 316(5832):1679. PubMed ID: 17588904
[No Abstract] [Full Text] [Related]
16. Breast carcinoma chemoprevention in the community setting. Estimating risks and benefits.
Brewster AM; Christo DK; Lai H; Helzlsouer K
Cancer; 2005 Mar; 103(6):1147-53. PubMed ID: 15674856
[TBL] [Abstract][Full Text] [Related]
17. National Cancer Institute--supported cancer chemoprevention research: coming of age.
McCaskill-Stevens W; Hawk ET; Flynn PJ; Lippman SM
J Clin Oncol; 1999 Nov; 17(11 Suppl):53-62. PubMed ID: 10630263
[No Abstract] [Full Text] [Related]
18. Older women unaware of increased breast cancer risk.
Cancer Pract; 2000; 8(2):57. PubMed ID: 11898176
[No Abstract] [Full Text] [Related]
19. Clinical trials: a recent emphasis in the prevention program of the National Cancer Institute.
DeWys WD; Greenwald P
Semin Oncol; 1983 Sep; 10(3):360-4. PubMed ID: 6665563
[No Abstract] [Full Text] [Related]
20. The breast cancer prevention trial.
Kardinal CG
J La State Med Soc; 1992 Apr; 144(4):167-8. PubMed ID: 1613308
[No Abstract] [Full Text] [Related]
[Next] [New Search]
